Nanotechnology Platform for Identification of Ligand Binding Sites on a Protein

Diagnostic Assays/Devices

Nanotechnology Platform for Identification of Ligand Binding Sites on a Protein

Methods for Improving Low Magnification Dark-Field Assays

Label-Free Detection, Identification & Quantification of Single Proteins

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates

High Speed, High Fidelity, High Sensitivity, Nucleic Acid Detection

Structure Assisted Directed Evolution of Multivalent Ligands

Biosensors for Continuous Detection of Analytes

Autoantibodies for Identification of False Positives of Disease and Uses Thereof

Biomarkers for the Early Detection of Breast Cancer